A two-component research blend combining 5 mg tesamorelin and 5 mg ipamorelin, for 10 mg total declared content.

Material at a glance

• Declared content: 10 mg per vial
• Format: Lyophilized powder
• Product identifier: PF-TESAIPA10
• Tesamorelin — 5 mg
• Ipamorelin — 5 mg

Bigger isn’t always better.

Small production lots of 1,000 units or fewer. A new lot-specific certificate of analysis for every 1,000 units.

Developed, packaged and independently tested in the USA. Each arriving lot is held for testing. Products are released only after testing is complete and the lot’s COA is released and approved.

Preorders reserve incoming material. Dispatch follows completed testing and approved COA release.

explore our testing approach.

Analytical documentation

No lot-specific certificate is published for this SKU yet. A certificate for another strength or blend does not establish results for this material. Refer to the availability shown above for the current purchase status.

Declared content describes the product specification; measured content and purity are separate analytical results. Certificates apply to the sample and lot identified in the report.

RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL USE. For legitimate laboratory research and analytical applications. Not intended for administration, consumption or clinical use.